SCHEMBL6897038

SCHEMBL6897038

COC(=O)c1cccc2c1c1c(O)cc(-c3ccc(Cl)cc3)cc1n2Cc1cccc(Cl)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 8/20 0.46
MAPT P10636 3/20 0.46
POLB P06746 1/20 0.45
DRD2 P14416 2/20 0.43
TBXA2R P21731 2/20 0.43
SLC6A4 P31645 1/20 0.40
SLC6A3 Q01959 1/20 0.40
P2RX7 Q99572 1/20 0.40
PLA2G1B P04054 1/20 0.40
CCR2 P41597 2/20 0.40
ALDH1A1 P00352 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
MAPK10 P53779 1/20 0.39
GRIN1 Q05586 1/20 0.39
GRIN2B Q13224 1/20 0.39
ABCB1 P08183 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6893709 0.94 MAPT (0.47) PLA2G2AMAPTPOLBPLA2G1BCCR2
SCHEMBL6690879 0.94 DRD2 (0.47) PLA2G2AMAPTPOLBDRD2TBXA2R
SCHEMBL6890338 0.92 MAPT (0.44) PLA2G2AMAPTPOLBDRD2TBXA2R
SCHEMBL6894303 0.92 DRD2 (0.44) PLA2G2AMAPTPOLBDRD2TBXA2R
SCHEMBL6897098 0.92 CYP19A1 (0.44) PLA2G2AMAPTPOLBDRD2TBXA2R
SCHEMBL6894657 0.92 MAPT (0.42) PLA2G2AMAPTPOLBDRD2TBXA2R
SCHEMBL6892182 0.91 DRD2 (0.43) PLA2G2AMAPTPOLBDRD2TBXA2R
SCHEMBL6895025 0.89 GRIN1 (0.45) POLBDRD2TBXA2RP2RX7CCR2
SCHEMBL6895281 0.89 FAAH (0.44) MAPTDRD2TBXA2RSLC6A4SLC6A3
SCHEMBL6890365 0.89 PPARG (0.46) MAPTDRD2TBXA2RMAPK10GRIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6713645-B1 INHIBITING SPLA2 MEDIATED RELEASE OF FATTY ACIDS FOR TREATMENT OF CONDITIONS SUCH AS SEPTIC SHOCK ELI LILLY AND COMPANY 2004-03-30 US disclosed
US-6177440-B1 THERAPY FOR SEPSIS SHOCK; PHOSPHOLIPASE INHBITOR ELI LILLY AND COMPANY 2001-01-23 US disclosed
EP-0952149-A2 Substituted carbazoles, process for their preparation and their use as sPLA2 inhibitiors ELI LILLY AND COMPANY (US) 1999-10-27 EP disclosed